Catalyst Wire Dossier Catalyst Wire Dossier

AZD3293 (lanabecestat)

lanabecestat · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD3293 (lanabecestat), covering 2013-08-27 to 2013-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects [Phase 1]

See pricing